Progress in Parkinson Research pp 67-76 | Cite as
Isolation And Biochemical Characterization Of The D1 And D2 Dopamine Receptors
Abstract
The catecholamine, dopamine, exerts physiologic effects in both the central nervous system and the periphery. Dopamine systems in the central nervous system (CNS) have been implicated in several neurologic and psychiatric disorders such as Parkinsonism, schizophrenia, Huntington’s chorea, Tourette’s syndrome, and Lesch-Nyhan syndrome. In the periphery, dopamine plays a role in processes controlling renal vascular tone and release of the hormones, prolactin from the anterior pituitary gland and parathyroid hormone from the parathyroid gland. The symptoms of some pathological processes are ameliorated through the use of drugs targeted toward the receptors for dopamine. For example, dopamine agonists have been successfully used to treat Parkinson’s disease, hyperprolactinemia (prolactinomas), and to prevent renal ischemia associated with cardiovascular collapse (shock), and dopamine antagonists have proven useful in the treatment of schizophrenia, and Tourette’s syndrome.
Keywords
Dopamine Receptor Guanine Nucleotide Binding Protein Striatal Tissue Photoaffinity Labelling Renal Vascular TonePreview
Unable to display preview. Download preview PDF.
References
- Amlaiky, N. & Caron., M.G. (1985) Photoaffinity of the D2-dopamine receptor using a novel high affinity radio-iodinated probe. J. Biol. Chem. 260: 1983–1986.PubMedGoogle Scholar
- Amilaiky. N. Berger, J.G., Chang, W., McQuade, R.J., & Caron, M.G. (1987) Identification of the binding subunit of the D1-dopamine receptor by photoaffinity crosslinking. Mol. Pharmacol. 31: 129–134.Google Scholar
- Amlaiky, N. and Caron, M.G., (1986) Identification of the D2-dopamine receptor binding subunit in several mammalian tissues and species by photoaffinity labelling. J. Neurochem. 47: 196–204.PubMedCrossRefGoogle Scholar
- Arnt, J. (1987) Behavioral studies of dopamine receptors: evidence for regional selectivity and receptor multiplicity. in Dopamine Receptors, (Creese, I., & Fraiser, C.M., eds.) pp. 199–231, Alan R. Liss, New York.Google Scholar
- Barone, P., Davis, T.A., Braun, A.R., & Chase, T.N. (1986) Dopaminergic mechanisms and motor function: characterization of D-l and D-2 dopamine receptor interactions. Eur. J. Pharmacol. 123: 109–114.PubMedCrossRefGoogle Scholar
- Billard, W., Ruperto, V., Crosby, G., Iorio, L. C., & Barnett, A. (1984) Characterization of the binding of [3H]SCH 23390, a selective D-l receptor antagonist ligand in rat striatum. Life Sci. 35: 1885–1893.PubMedCrossRefGoogle Scholar
- Caron, M.G., Kilpatrick, B.F., and De Lean, A. (1983) The dopamine receptor of the anterior pituitary gland: Ligand binding and solubilization studies, in Dopamine Receptors (C. Kaiser and J.W. Kebabian, eds). ACS Symposium Series 224, pp. 73–92.CrossRefGoogle Scholar
- Christensen, A.V., Arnt, J., Hyttel, J., Larsen, J., & Svendsen, O. (1984) Pharmacological effects of specific dopamine D-l antagonist SCH 23390 in comparison with neuroleptics. Life Sci. 34: 1529–1540.PubMedCrossRefGoogle Scholar
- Clark, D., and White, F.J., (1987) Review: D1 dopamine receptor-The search for a function: A critical evaluation of the D1/D2 dopamine receptor classification and its functional implications. Synapse. 1:347–388.PubMedCrossRefGoogle Scholar
- DeLean, A.U., Kilpatrick B.R., & Caron, M.G. (1982) Dopamine receptor of the porcine anterior pituitary gland: Evidence for two affinity states discriminated by both agonists and antagonists. Mol. Pharmacol. 22:290–297.PubMedGoogle Scholar
- Enjalbert, A., Sladeczek, F., Guillon, G., Bertrand, P., Shu, C., Epelbaum, J., Garcia-Sainz, A., Jard, S., Lombard, C., Kordon, C., & Bockaert, J., (1986) Angiotensin II and dopamine modulate both cAMP and inositol phosphate productions in anterior pituitary cells. J. Biol. Chem. 261:4071–4075.PubMedGoogle Scholar
- Gershanik, O., Heikkila, R.E., & Duvoisin, R.C. (1983) Behavioral correlations of dopamine receptor activation. Neurology. 33:1489–1492.PubMedGoogle Scholar
- Gingrich, J.A., Amlaiky, N., Senogles, S.E., Chang, W.K., McQuade, R.D., Berger, J.G., Caron, M.G., (1988) Affinity chromatography of the D1 dopamine receptor from rat corpus striatum, FASEB abstract.Google Scholar
- Iorio, L.C., Barnett, A., Leitz, F.H., Houser, V.P., & Korduba, C. A. (1983) SCH 23390, apotential benzazepine antipsychotic with unique interactions on dopaminergic systems. J. Pharmacol, and Exp. Therap. 226:63–468.Google Scholar
- Kebabian, J.W. & Calne, D.B. (1979) Multiple receptors for dopamine. Nature 277:93–96.PubMedCrossRefGoogle Scholar
- Kebabian, J.W. & Greengard, P. (1971) Dopamine-sensitive adenyl cyclase: possible role in synaptic transmission. Science 174:1346–1349.PubMedCrossRefGoogle Scholar
- Kilpatrick, B.F. and Caron, M.G. (1983) Agonist binding promotes a guanine nucleotide reversible increase in the apparent size of the bovine anterior pituitary dopamine receptor. J. Biol, chem 258:13528–13534.PubMedGoogle Scholar
- Kilpatrick, B.F. and Caron, I. (1984) Dopamine receptor of the porcine anterior pituitary band: Solubilization and characterization. Biochem. Fkrmacol. 33:1981–1988.CrossRefGoogle Scholar
- Leff, S.E., & Creese, I. (1985b) Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum. Mol. Pharmacol. 27:184–192PubMedGoogle Scholar
- Margaroli, A., Vallai, L., Elaki, F.R., Pozzan, T., Spada, A., and Meldolesi, J. (1987) Dopamine inhibits cytosolic Ca+ + increases in rat lactotroph cells: Evidence of a dual mechanism of action. J. Bil. Chem. 262:1390–13927.Google Scholar
- Robertson, G.S. & Robertson, H.A. (1986) Synergistic effects of D1 and D2 dopamine agonists on turning behavior in rats. Eur. J. Pharmacol. 384:387–390.Google Scholar
- Sasaki, K. & Soto, M. (1987) A single GTP-binding protein regulated K + -channels coupled with dopamine, histamine and acetylcholine receptors. Nature. 325:259–262.PubMedCrossRefGoogle Scholar
- Seeman, P. (1980) Brian dopamine receptors. Pharm. Rev. 32:229–313.PubMedGoogle Scholar
- Senogles, S.E., Amlaiky, N., Johnson, A.L., & Caron, M.G. (1986) Affinity chromotography of the anterior pituitary D2-dopamine receptor. Biochemistry 25:749–753.PubMedCrossRefGoogle Scholar
- Senogles, S.E., Benovic, J.L., Amlaiky, N., Unson, C., Milligan, G., Vinitksy, R., Spiegel, A., and Caron, M.G., (1987) The D2 dopamine receptor of anterior pituitary is functionally associated with a pertussis toxin-sensitive guanine nucleotide binding protein. J. Biol. Chem. 262:3106–3113.Google Scholar
- Senogles, S.E., Amlaiky, N., & Caron, M.G., (1988) Purification of the D2 dopamine receptor from anterior pituitary. FASEB abstract.Google Scholar
- Stoff, J.C. & Kebabian, J.W. (1984) Two domapine receptors: biochemistry and pharmacology. Life Sci, 35:2281–2296.CrossRefGoogle Scholar
- Waddington, J.L. (1986) Behavioral correlates of the action of selective D-l dopamine receptor antagonists. Biochem. Pharmacol. 35:3661–3667.PubMedCrossRefGoogle Scholar
- Walters, J.R., Bergstrom, D.A., Carlson, J.H., Chase, T., & Braun, A.L. (1987) D1 Dopamine receptor activation required for postsynaptic expression of D2 agonist effects Science 236:719–722.PubMedCrossRefGoogle Scholar